Login / Signup

[Experience in the use of cladribine for the treatment of patients with highly active forms of multiple sclerosis in the Moscow region].

T I YakushinaD M YakushinV Yu LijdvoyYu A Belova
Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2024)
The results obtained indicate the high efficacy and favorable safety profile of cladribine and are consistent with the data of clinical trials of the drug.
Keyphrases
  • multiple sclerosis
  • clinical trial
  • electronic health record
  • big data
  • randomized controlled trial
  • emergency department
  • phase ii
  • deep learning
  • replacement therapy
  • adverse drug
  • data analysis
  • smoking cessation